Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17787
Title: Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy.
Authors: Christidis, Daniel;Clarebrough, E;Ly, V;Perera, Marlon;Woo, H;Lawrentschuk, Nathan L ;Bolton, Damien M
Affiliation: Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Young Urology Researchers Organization, Melbourne, Australia
Department of Surgery, St. Vincent's Hospital, Melbourne, Australia
Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, NSW, Australia
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Apr-2018
EDate: 2018-02-14
Citation: World journal of urology 2018; 36(4): 575-584
Abstract: Prostatic artery embolization (PAE) has seen a recent increase in interest as a treatment for men with benign prostatic obstruction (BPO). The appeal of this intervention lies in reported reduction in morbidity and its minimally invasive nature. The purpose of this review is to assess the safety and efficacy of PAE as a new treatment in BPO and explore risks surrounding its performance. A review of the literature was performed. Medical databases searched included PubMed, EMBASE, and Cochrane databases, limited to English, peer-reviewed articles. Search terms included prostatic artery embolization, lower urinary tracts symptoms, minimally invasive therapies, interventional radiology prostate, and benign prostatic hyperplasia. Articles were screened by two independent reviewers for content on development, methods, outcomes, and complications of PAE. Suitability of patients to undergo PAE depends on review of patient history, pre-procedure visualisation of appropriate vascular anatomy and clinical parameters. Despite this selection of candidates favourable for procedural success, PAE is not without risk of complications, some of which can significantly affect patient quality of life. Although initial findings show promise regarding safety and efficacy of PAE in improving symptom and quality-of-life scores, further investigation is required to establish durability of effect and the appropriate use of this experimental modality. There is currently limited robust evidence for the beneficial outcomes of PAE. Long-term follow-up studies will add to the evidence base to help further assess the feasibility of this procedure as an alternative to TURP.
URI: http://ahro.austin.org.au/austinjspui/handle/1/17787
DOI: 10.1007/s00345-018-2220-z
ORCID: 0000-0003-2951-3726
0000-0002-1138-6389
0000-0001-8553-5618
0000-0002-5145-6783
PubMed URL: 29445846
Type: Journal Article
Review
Subjects: Benign prostatic hyperplasia
Interventional radiology prostate
Lower urinary tracts symptoms
Minimally invasive therapies
Prostatic artery embolization
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.